SCHEMBL24399382

SCHEMBL24399382

CCc1cccc2oncc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.42
GABRA1 P14867 4/20 0.39
GABRB2 P47870 4/20 0.39
DAO P14920 1/20 0.37
DDO Q99489 1/20 0.37
KCNA5 P22460 1/20 0.35
ELANE P08246 3/20 0.33
RECQL P46063 1/20 0.33
LMNA P02545 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
SLC9A1 P19634 1/20 0.32
KMT2A Q03164 1/20 0.32
FAAH O00519 1/20 0.32
MGLL Q99685 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1272633 0.81 BRD4 (0.38) BRD4LMNASMN1; SMN2CA12CA1
SCHEMBL21807206 0.81 LMNA (0.41) BRD4LMNASMN1; SMN2L3MBTL1KDM4E
SCHEMBL24499203 0.80 BRD4 (0.39) BRD4KCNA5SMN1; SMN2
SCHEMBL1272631 0.78 CA12 (0.37) BRD4LMNASMN1; SMN2CA12CA1
SCHEMBL17240948 0.74 MEN1 (0.49) LMNASMN1; SMN2ALDH1A1KMT2A
SCHEMBL2005190 0.74 BRD4 (0.41) BRD4LMNASMN1; SMN2CA12CA1
SCHEMBL2005193 0.71 BRD4 (0.42) BRD4RECQLLMNASMN1; SMN2L3MBTL1
SCHEMBL24610590 0.70 BRD4 (0.33) BRD4
SCHEMBL17240950 0.70 BRD4 (0.35) BRD4LMNASMN1; SMN2L3MBTL1KDM4E
SCHEMBL20871562 0.69 BRD4 (0.41) BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196601-A1 OXADIAZOLE HDAC6 INHIBITORS AND USES THEREOF EIKONIZO THERAPEUTICS, INC. (US) 2023-10-12 WO disclosed
WO-2022094271-A1 METHODS FOR TREATING CANCER SCORPION THERAPEUTICS, INC. (US) 2022-05-05 WO disclosed